Monsanto Co. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Monsanto Co.

MTC 3.465

+4.1%

3:56 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John F Beule who wrote (627)	12/1/1998 9:14:00 AM
From: John F Beule	Read Replies (1) of 2539

Well, here's to hoping the FDA agrees with all us longs! I really don't believe yesterday's price is reflectant on potential approval, I believe it has seen recent strength due to the fact that mgmt is boldly moving ahead on their way to wanting to become a premier player in the life/sciences field. With the massive shares outstanding tho, if Celebrex is approved, we will see maybe 10% on the upside, maybe more due to the recent offering to "new" shareholders at $40. Analysts will upgrade to protect their clients. I see downside being greater (maybe 20%) due to the fact that MTC needs to pay off debt, and analysts are looking at this approval as MTC's gravy train to get them where they need to be financially. I wonder who has more at risk, PZE or MTC in todays decision? fingers are crossed....

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next